Cargando…
Trajectories of fatigue in actively treated patients with established rheumatoid arthritis starting biologic DMARD therapy
OBJECTIVES: To define fatigue trajectories in patients with rheumatoid arthritis (RA) who initiate biological DMARD (bDMARD) treatment, and explore baseline predictors for a trajectory of continued fatigue. METHODS: One-hundred and eighty-four patients with RA initiating bDMARDs were assessed at 0,...
Autores principales: | Provan, Sella Aarrestad, Michelsen, Brigitte, Sexton, Joseph, Uhlig, Tillmann, Hammer, Hilde Berner |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856128/ https://www.ncbi.nlm.nih.gov/pubmed/33214326 http://dx.doi.org/10.1136/rmdopen-2020-001372 |
Ejemplares similares
-
Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs: results from four Nordic countries
por: Delcoigne, Benedicte, et al.
Publicado: (2022) -
Fatigue in patients with early rheumatoid arthritis undergoing treat-to-target therapy: predictors and response to treatment
por: Holten, Karen, et al.
Publicado: (2022) -
Intermetatarsal bursitis is frequent in patients with established rheumatoid arthritis and is associated with anti-cyclic citrullinated peptide and rheumatoid factor
por: Hammer, Hilde Berner, et al.
Publicado: (2019) -
Fatigue is cross-sectionally not associated with objective assessments of inflammation, but changes in fatigue are associated with changes of disease activity assessments during biologic treatment of patients with established rheumatoid arthritis
por: Hammer, Hilde Berner, et al.
Publicado: (2020) -
Inflammation and biologic therapy in patients with rheumatoid arthritis achieving versus not achieving ACR/EULAR Boolean remission in a treat-to-target study
por: Paulshus Sundlisæter, Nina, et al.
Publicado: (2022)